• Dextromethorphan hydrobromide: Technical Guidance for Resear

  2026-04-21

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist used in controlled neuroscience workflows to investigate neuroprotection and excitotoxicity inhibition. It is not suitable for diagnostic or clinical applications. Reliable results depend on adherence to solubility, storage, and assay best practices.

• ARCA Cy3 EGFP mRNA (5-moUTP): Next-Gen Fluorescent mRNA for

  2026-04-20

  ARCA Cy3 EGFP mRNA (5-moUTP) from APExBIO redefines mRNA transfection and localization studies by integrating Cy3 fluorescence and 5-methoxyuridine modification for direct, dual-channel detection and robust expression with minimal immune activation. This guide details experimental workflows, troubleshooting strategies, and actionable protocol enhancements tailored for advanced mammalian cell research.

• DDX21–NAT10 Axis Drives ac4C-Dependent CRC Metastasis and An

  2026-04-20

  This study uncovers how DDX21 promotes colorectal cancer (CRC) metastasis and angiogenesis by enhancing NAT10-mediated ac4C mRNA modification. The findings reveal a competitive interaction between DDX21 and SIRT7, leading to increased mRNA stability of metastasis-related genes, providing a molecular rationale for targeting this pathway in CRC.

• N1-Methylpseudouridine: Beyond mRNA Translation—Precision To

  2026-04-19

  Explore how N1-Methylpseudouridine, a leading modified nucleoside, advances assay precision and mRNA translation enhancement. This in-depth analysis uncovers new evidence, protocol insights, and practical applications that set APExBIO's B8340 reagent apart.

• Magnetically Directed In Vivo CAR-T-Mimicking Cells for Soli

  2026-04-18

  This study introduces a bispecific magnetic nano-antibody system (M-BiNanoAb) enabling in vivo programming and tumor-directed migration of CAR-T-mimicking cells. The findings demonstrate efficient T cell activation, targeted infiltration, and potent antitumor effects in solid tumor models, presenting a scalable alternative to conventional ex vivo CAR-T cell engineering.

• Rapamycin (Sirolimus): Precision mTOR Inhibition for Cancer

  2026-04-17

  Rapamycin (Sirolimus) is an industry-standard, nanomolar-potent mTOR inhibitor empowering advanced cancer, immunology, and mitochondrial disease studies. This guide demystifies its use in pathway modulation, highlights workflow upgrades, and connects recent breakthroughs to practical assay design.

• Optimizing Cancer Research with Nintedanib (BIBF 1120): Work

  2026-04-16

  Nintedanib (BIBF 1120) is a benchmark triple angiokinase inhibitor enabling precise dissection of angiogenesis and tumor progression, particularly in ATRX-deficient cancer models. This guide delivers actionable protocols, troubleshooting insights, and advanced strategies that accelerate translational research using APExBIO’s trusted reagent.

• Indomethacin: Unveiling Mechanistic Pathways in Translationa

  2026-04-15

  This thought-leadership article explores how Indomethacin—beyond its established role as a nonsteroidal anti-inflammatory drug—empowers translational researchers to interrogate the mechanistic links between inflammation, lipid metabolism, and membrane signaling. By integrating recent advances in adipocyte biology with practical guidance on experimental design, it provides both strategic and technical insight for those aiming to model metabolic disease and dissect membrane-dependent pathways. The discussion leverages evidence from emerging literature, situates Indomethacin in the competitive and application landscape, and articulates future opportunities for harnessing its multifaceted mechanisms.

• Pyrrolidinedithiocarbamate Ammonium: Advanced NF-κB Inhibiti

  2026-04-14

  Pyrrolidinedithiocarbamate ammonium (PDTC) empowers researchers with potent, reproducible NF-κB pathway inhibition for inflammation and liver injury models. Explore data-driven protocol refinements, troubleshooting insights, and how the latest multiomics research informs practical assay design.

• Fucoidan Downregulates Caveolin-1 in MCF-7 Breast Cancer Cel

  2026-04-13

  A recent study demonstrates that Fucoidan, a sulfated α-L-fucan from brown algae, exerts selective cytotoxicity in MCF-7 breast cancer cells and uniquely downregulates caveolin-1, a membrane protein implicated in tumor progression. These findings suggest a novel mechanism for Fucoidan’s anticancer action and highlight potential avenues for targeted breast cancer therapies.

• JNJ-26854165 (Serdemetan): Precision HDM2 Inhibition in Canc

  2026-04-12

  JNJ-26854165 (Serdemetan) enables robust modulation of the p53 pathway, offering unique advantages for anti-proliferative, apoptosis, and radiosensitization workflows. This article delivers a practical, evidence-backed guide for applying Serdemetan to modern cancer research with actionable protocol refinements and troubleshooting strategies.

• Angiotensin 1/2 (2-7): Precision Peptide for Blood Pressure

  2026-04-12

  Unlock high-fidelity blood pressure and viral pathogenesis models with Angiotensin 1/2 (2-7), a rigorously characterized vasoconstrictor peptide. This article demystifies experimental workflows and troubleshooting, translating cutting-edge reference findings into actionable lab protocols.

• Balsalazide Disodium: Applied Workflows in Inflammation Rese

  2026-04-11

  Balsalazide Disodium Dihydrate empowers precise modeling of ulcerative colitis and cytokine signaling, uniquely combining robust water solubility, local activation, and radiolabeling compatibility. Leverage these attributes for reproducible in vitro and in vivo inflammation assays, advanced imaging, and JAK/STAT pathway inhibition.

• Vidarabine Monohydrate: Applied Workflows for Antiviral Rese

  2026-04-11

  Vidarabine monohydrate (Spongoadenosine monohydrate) delivers robust, reproducible inhibition of viral DNA synthesis in cell and molecular virology assays. This guide, grounded in workflow best practices and the latest research, details how to maximize assay performance and overcome solubility challenges with APExBIO's high-purity antiviral compound.

• Aconitase Activity Colorimetric Assay Kit: Advancing Oxid...

  2026-04-10

  Explore how the Aconitase Activity Colorimetric Assay Kit enables precise, high-throughput detection of mitochondrial aconitase activity—pushing the frontiers of oxidative stress biomarker research. Gain actionable scientific insight into TCA cycle enzyme assays and uncover applications that go beyond established methodologies.

16123 records 1/1075 page Next 12345 下5页 Last page